Brief: Cipher Pharmaceuticals Reports Q4 Revenue Of $6.1 Mln
March 18 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR 2020
FINANCIAL RESULTS
* CIPHER PHARMACEUTICALS INC - QTRLY TOTAL REVENUE INCREASED
3.4%
TO $6.1 MILLION FROM $5.9 MILLION
* CIPHER PHARMACEUTICALS - QTRLY LOSS FROM CONTINUING
OPERATIONS
WAS $0.1 MILLION, OR LOSS OF $0.00 PER BASIC & DILUTED SHARE
Source text for Eikon: ID:nCNWfBlVJa
Further company coverage: CPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million